Corcept Therapeutics Incorporated
CORT
$69.57
$0.751.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.09% | 13.53% | 33.04% | 55.19% | 33.15% |
| Total Depreciation and Amortization | 101.49% | -3.75% | -43.44% | -65.36% | -75.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.03% | 26.27% | -0.91% | -39.85% | -11.78% |
| Change in Net Operating Assets | 360.43% | 652.58% | 451.27% | -107.90% | -145.16% |
| Cash from Operations | 47.24% | 43.74% | 55.92% | -6.39% | -8.53% |
| Capital Expenditure | -323.18% | -1,537.41% | -1,462.59% | -1,106.47% | 6.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.49% | -35.11% | -292.69% | -265.84% | -199.63% |
| Cash from Investing | 74.37% | -36.77% | -295.37% | -269.97% | -200.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 163.79% | 86.87% | 65.48% | 85.23% | 46.19% |
| Repurchase of Common Stock | -1,282.64% | 49.21% | 75.43% | 79.29% | 91.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,781.96% | 54.76% | 80.94% | 84.61% | 96.34% |
| Foreign Exchange rate Adjustments | 30,000.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.98% | 60.10% | -111.39% | -58.59% | -131.96% |